Ambu A/S (CPH:AMBU.B)

Market Cap	27.44B
Revenue (ttm)	5.83B
Net Income (ttm)	370.00M
Shares Out	266.39M
EPS (ttm)	1.38
PE Ratio	74.55
Forward PE	36.10
Dividend	0.38 (0.37%)
Ex-Dividend Date	Dec 5, 2024

Volume	539,710
Average Volume	604,708
Open	103.40
Previous Close	103.00
Day's Range	101.00 - 104.20
52-Week Range	101.00 - 154.60
Beta	1.28
RSI	34.34
Earnings Date	May 7, 2025

About Ambu A/S

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1937
• Employees: 5,196
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: AMBU.B

Financial Performance

In 2024, Ambu A/S's revenue was 5.39 billion, an increase of 12.90% compared to the previous year's 4.78 billion. Earnings were 235.00 million, an increase of 39.88%.